| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bile Acids and Salts | 44 | 2021 | 172 | 3.810 |
Why?
|
| Cholestasis | 24 | 2022 | 225 | 3.290 |
Why?
|
| Liver | 70 | 2022 | 1693 | 3.180 |
Why?
|
| Carrier Proteins | 34 | 2011 | 703 | 2.690 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 15 | 2021 | 195 | 2.450 |
Why?
|
| ATP-Binding Cassette Transporters | 18 | 2021 | 123 | 1.730 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 21 | 2011 | 28 | 1.710 |
Why?
|
| Symporters | 21 | 2011 | 52 | 1.680 |
Why?
|
| Membrane Transport Proteins | 10 | 2016 | 137 | 1.380 |
Why?
|
| Gene Expression Regulation | 15 | 2021 | 2362 | 1.350 |
Why?
|
| Transcriptional Activation | 5 | 2016 | 341 | 1.320 |
Why?
|
| Taurocholic Acid | 25 | 2007 | 34 | 1.150 |
Why?
|
| Membrane Glycoproteins | 9 | 2011 | 429 | 1.140 |
Why?
|
| Cell Membrane | 24 | 2016 | 682 | 1.100 |
Why?
|
| Cholestasis, Intrahepatic | 8 | 2021 | 40 | 0.990 |
Why?
|
| Biliary Atresia | 9 | 2018 | 185 | 0.870 |
Why?
|
| Liver Transplantation | 19 | 2021 | 830 | 0.770 |
Why?
|
| Lactose Intolerance | 2 | 2010 | 2 | 0.720 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2012 | 96 | 0.720 |
Why?
|
| Hydroxysteroid Dehydrogenases | 7 | 2002 | 8 | 0.710 |
Why?
|
| Sodium | 13 | 2006 | 182 | 0.640 |
Why?
|
| Rats | 52 | 2008 | 5035 | 0.630 |
Why?
|
| Response Elements | 2 | 2016 | 83 | 0.630 |
Why?
|
| Liver Diseases | 10 | 2022 | 263 | 0.620 |
Why?
|
| Alagille Syndrome | 5 | 2022 | 35 | 0.620 |
Why?
|
| Animals | 82 | 2021 | 32123 | 0.600 |
Why?
|
| Kidney | 7 | 2013 | 1208 | 0.590 |
Why?
|
| Adenosine Triphosphatases | 11 | 2021 | 156 | 0.580 |
Why?
|
| Hepatocytes | 6 | 2021 | 197 | 0.580 |
Why?
|
| MicroRNAs | 2 | 2021 | 610 | 0.570 |
Why?
|
| Ileum | 10 | 2006 | 93 | 0.530 |
Why?
|
| Transcription Factor RelA | 1 | 2016 | 83 | 0.520 |
Why?
|
| Bile Ducts | 3 | 2011 | 73 | 0.500 |
Why?
|
| Histone Demethylases | 1 | 2015 | 28 | 0.500 |
Why?
|
| Bile Canaliculi | 8 | 2004 | 11 | 0.480 |
Why?
|
| Bile | 9 | 2012 | 26 | 0.470 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2013 | 50 | 0.450 |
Why?
|
| DNA-Binding Proteins | 10 | 2013 | 1319 | 0.450 |
Why?
|
| Petromyzon | 1 | 2013 | 3 | 0.450 |
Why?
|
| Liver Failure | 6 | 2011 | 84 | 0.450 |
Why?
|
| Sumoylation | 1 | 2013 | 15 | 0.440 |
Why?
|
| Transcription Factors | 10 | 2016 | 1531 | 0.440 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2013 | 4 | 0.390 |
Why?
|
| Promoter Regions, Genetic | 10 | 2016 | 1129 | 0.390 |
Why?
|
| Lysine | 2 | 2013 | 243 | 0.390 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2011 | 3 | 0.380 |
Why?
|
| Protein Binding | 8 | 2016 | 1919 | 0.360 |
Why?
|
| Histones | 3 | 2011 | 539 | 0.360 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2013 | 346 | 0.340 |
Why?
|
| RNA, Messenger | 21 | 2021 | 2581 | 0.330 |
Why?
|
| Rats, Inbred Strains | 20 | 1991 | 376 | 0.330 |
Why?
|
| Biological Transport | 18 | 1998 | 373 | 0.320 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 546 | 0.310 |
Why?
|
| Parenteral Nutrition | 4 | 2021 | 93 | 0.310 |
Why?
|
| Humans | 86 | 2022 | 115908 | 0.310 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 2 | 2007 | 13 | 0.310 |
Why?
|
| Male | 67 | 2021 | 56128 | 0.300 |
Why?
|
| COS Cells | 5 | 2007 | 176 | 0.300 |
Why?
|
| Feeding Behavior | 2 | 2010 | 573 | 0.300 |
Why?
|
| Molecular Sequence Data | 8 | 2013 | 2793 | 0.290 |
Why?
|
| Cholesterol | 6 | 2013 | 367 | 0.290 |
Why?
|
| Aging | 14 | 2003 | 1640 | 0.290 |
Why?
|
| Fetus | 6 | 2003 | 703 | 0.280 |
Why?
|
| Transfection | 9 | 2013 | 866 | 0.280 |
Why?
|
| Caroli Disease | 1 | 2006 | 1 | 0.270 |
Why?
|
| Methylation | 4 | 2012 | 206 | 0.270 |
Why?
|
| Animals, Newborn | 8 | 2003 | 780 | 0.260 |
Why?
|
| Mice | 15 | 2021 | 15075 | 0.260 |
Why?
|
| Awards and Prizes | 1 | 2006 | 56 | 0.260 |
Why?
|
| Protein Transport | 5 | 2016 | 400 | 0.250 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2006 | 55 | 0.250 |
Why?
|
| Infant | 32 | 2021 | 8002 | 0.250 |
Why?
|
| Cysts | 1 | 2006 | 94 | 0.250 |
Why?
|
| Dogs | 5 | 2007 | 344 | 0.250 |
Why?
|
| Bile Ducts, Intrahepatic | 4 | 2021 | 48 | 0.250 |
Why?
|
| Health Status | 1 | 2010 | 733 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2005 | 2262 | 0.240 |
Why?
|
| Portoenterostomy, Hepatic | 4 | 2018 | 53 | 0.240 |
Why?
|
| Pediatrics | 4 | 2010 | 986 | 0.240 |
Why?
|
| Biliary Tract | 3 | 2005 | 16 | 0.240 |
Why?
|
| Taurine | 4 | 1988 | 41 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2007 | 616 | 0.230 |
Why?
|
| Jaundice | 1 | 2003 | 13 | 0.230 |
Why?
|
| Child | 38 | 2022 | 18555 | 0.230 |
Why?
|
| Chenodeoxycholic Acid | 3 | 2021 | 12 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2018 | 510 | 0.210 |
Why?
|
| Research | 3 | 2005 | 398 | 0.210 |
Why?
|
| Pregnancy, Animal | 1 | 2003 | 53 | 0.210 |
Why?
|
| Gene Expression | 6 | 2021 | 1442 | 0.210 |
Why?
|
| Child, Preschool | 27 | 2021 | 9175 | 0.210 |
Why?
|
| Base Sequence | 8 | 2016 | 2120 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 1138 | 0.210 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 44 | 0.200 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.200 |
Why?
|
| Amino Acid Sequence | 6 | 2013 | 2000 | 0.200 |
Why?
|
| Transcription, Genetic | 6 | 2013 | 1318 | 0.200 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 73 | 0.200 |
Why?
|
| Isoxazoles | 1 | 2021 | 56 | 0.200 |
Why?
|
| Protein Sorting Signals | 1 | 2001 | 16 | 0.190 |
Why?
|
| Biliary Tract Diseases | 3 | 2002 | 34 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2004 | 796 | 0.190 |
Why?
|
| Chromatin | 3 | 2015 | 427 | 0.190 |
Why?
|
| Cyclic AMP | 4 | 2007 | 227 | 0.190 |
Why?
|
| Down-Regulation | 8 | 2011 | 605 | 0.190 |
Why?
|
| Female | 53 | 2021 | 60086 | 0.190 |
Why?
|
| Cytoplasm | 2 | 2004 | 255 | 0.190 |
Why?
|
| Mitochondrial Proteins | 1 | 2003 | 223 | 0.190 |
Why?
|
| Chromosome Mapping | 3 | 1999 | 503 | 0.190 |
Why?
|
| Cell Line | 7 | 2016 | 2655 | 0.190 |
Why?
|
| Infant, Newborn | 18 | 2018 | 5089 | 0.180 |
Why?
|
| Cells, Cultured | 11 | 2012 | 3916 | 0.180 |
Why?
|
| Biological Transport, Active | 9 | 2004 | 71 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 132 | 0.180 |
Why?
|
| Kinetics | 14 | 1997 | 1560 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 4769 | 0.180 |
Why?
|
| Dairy Products | 2 | 2010 | 30 | 0.180 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 370 | 0.170 |
Why?
|
| Blotting, Western | 6 | 2013 | 1153 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 337 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1999 | 12 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1999 | 28 | 0.170 |
Why?
|
| Liver Failure, Acute | 3 | 2010 | 60 | 0.170 |
Why?
|
| Failure to Thrive | 1 | 2018 | 32 | 0.160 |
Why?
|
| Oxidoreductases | 3 | 1994 | 92 | 0.160 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 28 | 0.150 |
Why?
|
| Arginine | 2 | 2013 | 241 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2749 | 0.150 |
Why?
|
| Bile Duct Diseases | 1 | 1998 | 17 | 0.150 |
Why?
|
| Immunosuppressive Agents | 3 | 2011 | 666 | 0.150 |
Why?
|
| Estrone | 2 | 2007 | 35 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2021 | 2606 | 0.140 |
Why?
|
| Graft Rejection | 5 | 2011 | 533 | 0.140 |
Why?
|
| Sarcopenia | 1 | 2018 | 68 | 0.140 |
Why?
|
| Caco-2 Cells | 3 | 2013 | 66 | 0.140 |
Why?
|
| Graft Survival | 8 | 2011 | 481 | 0.140 |
Why?
|
| Cloning, Molecular | 2 | 1995 | 522 | 0.140 |
Why?
|
| Amino Acid Motifs | 2 | 2016 | 198 | 0.140 |
Why?
|
| Bilirubin | 5 | 2021 | 91 | 0.140 |
Why?
|
| Methyltransferases | 2 | 2016 | 61 | 0.140 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2016 | 14 | 0.130 |
Why?
|
| Treatment Outcome | 12 | 2021 | 9166 | 0.130 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 16 | 0.130 |
Why?
|
| Metabolism, Inborn Errors | 2 | 1993 | 39 | 0.130 |
Why?
|
| ErbB Receptors | 2 | 1991 | 557 | 0.130 |
Why?
|
| Prolactin | 3 | 2005 | 95 | 0.130 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2006 | 15 | 0.130 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 92 | 0.130 |
Why?
|
| Vitamin E | 2 | 2012 | 111 | 0.130 |
Why?
|
| Organic Anion Transporters | 2 | 2005 | 15 | 0.130 |
Why?
|
| Endotoxins | 1 | 1996 | 208 | 0.130 |
Why?
|
| Enterohepatic Circulation | 4 | 1983 | 7 | 0.130 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 128 | 0.130 |
Why?
|
| Macrophages | 2 | 2021 | 1281 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2015 | 16 | 0.120 |
Why?
|
| Animals, Suckling | 5 | 1997 | 9 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 3582 | 0.120 |
Why?
|
| Pregnancy | 11 | 2005 | 5556 | 0.120 |
Why?
|
| Haplorhini | 2 | 2012 | 59 | 0.120 |
Why?
|
| Prognosis | 6 | 2021 | 3342 | 0.120 |
Why?
|
| Adenosine Triphosphate | 5 | 1997 | 430 | 0.120 |
Why?
|
| Adolescent | 20 | 2021 | 17955 | 0.120 |
Why?
|
| Jaundice, Neonatal | 2 | 2004 | 8 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 196 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2018 | 639 | 0.120 |
Why?
|
| Hemochromatosis | 1 | 1994 | 9 | 0.120 |
Why?
|
| Body Weight | 6 | 2018 | 872 | 0.120 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 4446 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2010 | 590 | 0.120 |
Why?
|
| Prednisolone | 1 | 2014 | 77 | 0.120 |
Why?
|
| Cell Nucleus | 5 | 2004 | 554 | 0.120 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2013 | 11 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 2014 | 83 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 1998 | 431 | 0.110 |
Why?
|
| Prevalence | 2 | 2010 | 2270 | 0.110 |
Why?
|
| Multidrug Resistance-Associated Proteins | 4 | 2021 | 36 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 528 | 0.110 |
Why?
|
| Xenobiotics | 1 | 2013 | 24 | 0.110 |
Why?
|
| DNA Helicases | 1 | 2015 | 133 | 0.110 |
Why?
|
| Liver Function Tests | 5 | 2011 | 105 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 74 | 0.110 |
Why?
|
| Plasmids | 3 | 2011 | 346 | 0.110 |
Why?
|
| Anion Exchange Resins | 1 | 1993 | 7 | 0.110 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2013 | 7 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2015 | 280 | 0.110 |
Why?
|
| Consensus Sequence | 1 | 2013 | 71 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 61 | 0.110 |
Why?
|
| SUMO-1 Protein | 1 | 2013 | 21 | 0.110 |
Why?
|
| Retinoid X Receptors | 1 | 2013 | 39 | 0.110 |
Why?
|
| Tissue and Organ Procurement | 3 | 2006 | 243 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2013 | 260 | 0.110 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2003 | 4 | 0.110 |
Why?
|
| Tretinoin | 1 | 2013 | 123 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 1998 | 965 | 0.110 |
Why?
|
| Ligands | 2 | 2013 | 568 | 0.110 |
Why?
|
| Avitaminosis | 1 | 2012 | 7 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 319 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2021 | 3004 | 0.110 |
Why?
|
| Vitamin K | 1 | 2012 | 42 | 0.100 |
Why?
|
| Antibodies | 1 | 1994 | 374 | 0.100 |
Why?
|
| Ligation | 2 | 2011 | 77 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 136 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 267 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 3 | 2008 | 377 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 304 | 0.100 |
Why?
|
| Glycocholic Acid | 4 | 1987 | 6 | 0.100 |
Why?
|
| Muromonab-CD3 | 1 | 2011 | 23 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2003 | 399 | 0.100 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 288 | 0.100 |
Why?
|
| Antilymphocyte Serum | 1 | 2011 | 66 | 0.100 |
Why?
|
| Mutation | 4 | 2021 | 3371 | 0.100 |
Why?
|
| Tyrosinemias | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2010 | 74 | 0.100 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 198 | 0.100 |
Why?
|
| Self Concept | 1 | 2013 | 218 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 538 | 0.090 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2010 | 32 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 1997 | 1033 | 0.090 |
Why?
|
| Mercaptopurine | 1 | 2010 | 15 | 0.090 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2010 | 16 | 0.090 |
Why?
|
| Antimetabolites | 1 | 2010 | 21 | 0.090 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 96 | 0.090 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2010 | 32 | 0.090 |
Why?
|
| Affect | 1 | 2013 | 244 | 0.090 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2010 | 25 | 0.090 |
Why?
|
| Oocytes | 2 | 2006 | 172 | 0.090 |
Why?
|
| Allopurinol | 1 | 2010 | 55 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 154 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 400 | 0.090 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2010 | 34 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2013 | 217 | 0.090 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2010 | 32 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 1994 | 675 | 0.090 |
Why?
|
| Amino Acids | 4 | 1998 | 455 | 0.090 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2010 | 4 | 0.090 |
Why?
|
| United States | 6 | 2010 | 12338 | 0.090 |
Why?
|
| Membrane Potentials | 4 | 1993 | 251 | 0.090 |
Why?
|
| Luminescent Proteins | 2 | 2001 | 169 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2010 | 128 | 0.090 |
Why?
|
| Immunoblotting | 3 | 1996 | 283 | 0.090 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1986 | 45 | 0.080 |
Why?
|
| End Stage Liver Disease | 1 | 2010 | 74 | 0.080 |
Why?
|
| Cholangiography | 2 | 2008 | 15 | 0.080 |
Why?
|
| Lipoproteins | 2 | 2021 | 162 | 0.080 |
Why?
|
| Diarrhea, Infantile | 3 | 1984 | 8 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2021 | 4526 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2012 | 460 | 0.080 |
Why?
|
| Cell Phone | 1 | 2009 | 78 | 0.080 |
Why?
|
| Acetylation | 2 | 2006 | 212 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 2011 | 246 | 0.080 |
Why?
|
| Liver Cirrhosis | 2 | 2022 | 240 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2008 | 13 | 0.080 |
Why?
|
| Forecasting | 1 | 2010 | 332 | 0.080 |
Why?
|
| Jejunum | 1 | 1988 | 24 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2007 | 132 | 0.080 |
Why?
|
| Molecular Weight | 3 | 1995 | 335 | 0.080 |
Why?
|
| Gastroenterology | 2 | 2002 | 158 | 0.080 |
Why?
|
| Steroid Hydroxylases | 2 | 2004 | 19 | 0.070 |
Why?
|
| RNA | 1 | 2013 | 821 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1991 | 394 | 0.070 |
Why?
|
| Placenta | 1 | 1993 | 623 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 521 | 0.070 |
Why?
|
| Golgi Apparatus | 1 | 2007 | 91 | 0.070 |
Why?
|
| Tritium | 2 | 2003 | 69 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2008 | 274 | 0.070 |
Why?
|
| Microsomes, Liver | 2 | 1997 | 57 | 0.070 |
Why?
|
| Risk Factors | 5 | 2011 | 8714 | 0.070 |
Why?
|
| Osteoporosis | 1 | 2010 | 227 | 0.070 |
Why?
|
| DNA Primers | 3 | 2001 | 513 | 0.070 |
Why?
|
| Obesity | 2 | 2013 | 2530 | 0.070 |
Why?
|
| Double-Blind Method | 3 | 2018 | 1665 | 0.070 |
Why?
|
| Dimerization | 1 | 2007 | 177 | 0.070 |
Why?
|
| Retrospective Studies | 9 | 2021 | 12616 | 0.070 |
Why?
|
| Genetics, Medical | 1 | 2006 | 26 | 0.070 |
Why?
|
| Intestinal Absorption | 3 | 1983 | 93 | 0.070 |
Why?
|
| Choledochal Cyst | 1 | 2006 | 17 | 0.070 |
Why?
|
| Xenopus laevis | 1 | 2006 | 117 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2006 | 202 | 0.070 |
Why?
|
| Resource Allocation | 1 | 2006 | 38 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 686 | 0.070 |
Why?
|
| Binding Sites | 3 | 2004 | 1183 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2006 | 164 | 0.070 |
Why?
|
| Digestive System Abnormalities | 1 | 2005 | 12 | 0.060 |
Why?
|
| Microvilli | 3 | 1993 | 70 | 0.060 |
Why?
|
| Young Adult | 7 | 2021 | 10518 | 0.060 |
Why?
|
| Health Care Rationing | 1 | 2005 | 47 | 0.060 |
Why?
|
| Lithocholic Acid | 2 | 1982 | 2 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2006 | 276 | 0.060 |
Why?
|
| Diarrhea | 2 | 1984 | 173 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 686 | 0.060 |
Why?
|
| Decision Support Techniques | 2 | 2006 | 352 | 0.060 |
Why?
|
| Abnormalities, Multiple | 2 | 2003 | 176 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2021 | 1221 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2005 | 99 | 0.060 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2004 | 34 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2009 | 536 | 0.060 |
Why?
|
| Pruritus | 1 | 2004 | 61 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2005 | 369 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 804 | 0.060 |
Why?
|
| Hepatitis C, Chronic | 1 | 2006 | 152 | 0.060 |
Why?
|
| Postoperative Care | 2 | 2018 | 222 | 0.060 |
Why?
|
| Phenotype | 3 | 2011 | 2861 | 0.060 |
Why?
|
| Time Factors | 6 | 2018 | 6186 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 647 | 0.060 |
Why?
|
| Adult | 13 | 2011 | 30820 | 0.060 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2004 | 79 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2016 | 604 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2005 | 200 | 0.060 |
Why?
|
| Cystic Fibrosis | 3 | 2011 | 961 | 0.060 |
Why?
|
| Bucladesine | 2 | 2000 | 23 | 0.060 |
Why?
|
| Infant Nutrition Disorders | 1 | 1983 | 11 | 0.060 |
Why?
|
| Cholic Acids | 5 | 1985 | 17 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 1243 | 0.050 |
Why?
|
| Endoglin | 1 | 2022 | 20 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 205 | 0.050 |
Why?
|
| Living Donors | 2 | 2010 | 324 | 0.050 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2003 | 89 | 0.050 |
Why?
|
| Liver X Receptors | 2 | 2018 | 30 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2022 | 24 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2003 | 70 | 0.050 |
Why?
|
| Rabbits | 3 | 2003 | 755 | 0.050 |
Why?
|
| Valproic Acid | 2 | 1979 | 43 | 0.050 |
Why?
|
| Protein Folding | 1 | 2004 | 242 | 0.050 |
Why?
|
| Phosphorylation | 5 | 2008 | 1561 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2011 | 1149 | 0.050 |
Why?
|
| Patient Selection | 1 | 2006 | 656 | 0.050 |
Why?
|
| Blotting, Northern | 3 | 1997 | 194 | 0.050 |
Why?
|
| Sterols | 1 | 2021 | 17 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 1998 | 49 | 0.050 |
Why?
|
| Quality of Life | 1 | 2013 | 2392 | 0.050 |
Why?
|
| Tissue Distribution | 3 | 1998 | 324 | 0.050 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 29 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 243 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 73 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2004 | 671 | 0.050 |
Why?
|
| Infliximab | 1 | 2021 | 94 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 38 | 0.050 |
Why?
|
| Biopsy | 3 | 2010 | 1056 | 0.050 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 1979 | 126 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 2437 | 0.050 |
Why?
|
| Survival Rate | 3 | 2010 | 1653 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2006 | 648 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2021 | 164 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2005 | 971 | 0.050 |
Why?
|
| Genomics | 1 | 2005 | 641 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 513 | 0.050 |
Why?
|
| Glycosylation | 1 | 2000 | 133 | 0.050 |
Why?
|
| Fatty Acids | 2 | 2004 | 385 | 0.050 |
Why?
|
| Ileal Diseases | 1 | 1980 | 9 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2000 | 327 | 0.040 |
Why?
|
| Tacrolimus | 2 | 2011 | 143 | 0.040 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1999 | 42 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2021 | 6267 | 0.040 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 1998 | 16 | 0.040 |
Why?
|
| Threonine | 1 | 1998 | 40 | 0.040 |
Why?
|
| Age Factors | 6 | 1993 | 2912 | 0.040 |
Why?
|
| Cephalometry | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2011 | 4960 | 0.040 |
Why?
|
| Anion Transport Proteins | 1 | 1998 | 8 | 0.040 |
Why?
|
| Drainage | 2 | 2014 | 151 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 609 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2000 | 484 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 1647 | 0.040 |
Why?
|
| Caspases, Initiator | 1 | 2018 | 18 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2011 | 961 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 1999 | 314 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1980 | 103 | 0.040 |
Why?
|
| Serine | 1 | 1998 | 125 | 0.040 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 1998 | 6 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1997 | 850 | 0.040 |
Why?
|
| Cell Polarity | 1 | 1998 | 131 | 0.040 |
Why?
|
| Biomarkers | 2 | 2022 | 3474 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 1998 | 298 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2018 | 141 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1989 | 1044 | 0.040 |
Why?
|
| Milk Proteins | 1 | 1997 | 36 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 313 | 0.040 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 227 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 745 | 0.040 |
Why?
|
| Potassium | 2 | 1988 | 128 | 0.040 |
Why?
|
| Caspases | 1 | 2018 | 245 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 1998 | 302 | 0.030 |
Why?
|
| Genomic Library | 1 | 1996 | 14 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 594 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 1996 | 28 | 0.030 |
Why?
|
| TATA Box | 1 | 1996 | 22 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 252 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 1548 | 0.030 |
Why?
|
| Phosphofructokinase-1 | 1 | 2016 | 6 | 0.030 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1996 | 5 | 0.030 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2016 | 21 | 0.030 |
Why?
|
| Luciferases | 1 | 1996 | 141 | 0.030 |
Why?
|
| Cholagogues and Choleretics | 2 | 2008 | 9 | 0.030 |
Why?
|
| Alleles | 2 | 1998 | 818 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 42 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 29 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 167 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 2598 | 0.030 |
Why?
|
| Sirtuins | 1 | 2016 | 32 | 0.030 |
Why?
|
| Autoradiography | 2 | 1987 | 71 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 38 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 138 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 177 | 0.030 |
Why?
|
| Introns | 1 | 1996 | 228 | 0.030 |
Why?
|
| Exons | 1 | 1996 | 303 | 0.030 |
Why?
|
| Reticulocytes | 1 | 1995 | 17 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 209 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1995 | 49 | 0.030 |
Why?
|
| Tissue Donors | 2 | 2006 | 331 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 78 | 0.030 |
Why?
|
| Immune Sera | 1 | 1994 | 80 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1996 | 186 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 153 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2011 | 2167 | 0.030 |
Why?
|
| Cricetinae | 1 | 1995 | 260 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1994 | 30 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 1995 | 114 | 0.030 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 1998 | 209 | 0.030 |
Why?
|
| Child Development | 1 | 2018 | 394 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1995 | 274 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 352 | 0.030 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 1993 | 5 | 0.030 |
Why?
|
| Progesterone Reductase | 1 | 1993 | 2 | 0.030 |
Why?
|
| Steroid Isomerases | 1 | 1993 | 2 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 438 | 0.030 |
Why?
|
| Waiting Lists | 2 | 2006 | 223 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 310 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1993 | 64 | 0.030 |
Why?
|
| Vitamin E Deficiency | 1 | 1993 | 42 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 3087 | 0.030 |
Why?
|
| Ions | 1 | 1993 | 62 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 374 | 0.030 |
Why?
|
| Mannitol | 1 | 1993 | 32 | 0.030 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 2 | 2003 | 3 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 389 | 0.030 |
Why?
|
| Retinol-Binding Proteins | 1 | 2012 | 13 | 0.030 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2012 | 11 | 0.030 |
Why?
|
| alpha-Tocopherol | 1 | 2012 | 24 | 0.030 |
Why?
|
| Vertebrates | 1 | 1993 | 56 | 0.030 |
Why?
|
| Vitamin A | 1 | 2012 | 52 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 758 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1993 | 357 | 0.030 |
Why?
|
| Simvastatin | 1 | 2012 | 60 | 0.030 |
Why?
|
| Body Image | 1 | 2013 | 75 | 0.030 |
Why?
|
| Proteolipids | 1 | 1991 | 28 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2014 | 731 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1991 | 90 | 0.020 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2011 | 2 | 0.020 |
Why?
|
| Hemangioendothelioma | 1 | 2011 | 12 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 664 | 0.020 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1991 | 8 | 0.020 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1991 | 12 | 0.020 |
Why?
|
| Hemangioma | 1 | 2011 | 41 | 0.020 |
Why?
|
| Heredity | 1 | 2011 | 12 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2011 | 77 | 0.020 |
Why?
|
| Polyethylene Glycols | 2 | 2012 | 576 | 0.020 |
Why?
|
| Organelles | 1 | 1991 | 51 | 0.020 |
Why?
|
| Disease Progression | 2 | 2011 | 2424 | 0.020 |
Why?
|
| Registries | 2 | 2011 | 1773 | 0.020 |
Why?
|
| Blister | 1 | 2010 | 43 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1990 | 20 | 0.020 |
Why?
|
| Transaminases | 1 | 2010 | 25 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 531 | 0.020 |
Why?
|
| Feces | 3 | 1983 | 374 | 0.020 |
Why?
|
| Cell Separation | 1 | 1991 | 293 | 0.020 |
Why?
|
| Temperature | 1 | 1993 | 590 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 83 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 100 | 0.020 |
Why?
|
| Homeostasis | 2 | 2008 | 576 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 502 | 0.020 |
Why?
|
| Anions | 1 | 1989 | 31 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2004 | 824 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2011 | 190 | 0.020 |
Why?
|
| Incidence | 1 | 1996 | 2333 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2013 | 246 | 0.020 |
Why?
|
| Alanine | 1 | 1989 | 103 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2013 | 361 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2009 | 65 | 0.020 |
Why?
|
| Vitamin D | 1 | 2012 | 341 | 0.020 |
Why?
|
| Infant, Premature | 2 | 1983 | 477 | 0.020 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2008 | 21 | 0.020 |
Why?
|
| Lidocaine | 1 | 1989 | 42 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1988 | 25 | 0.020 |
Why?
|
| Mitochondria, Liver | 3 | 1983 | 66 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 1998 | 78 | 0.020 |
Why?
|
| Cortisone | 2 | 1985 | 9 | 0.020 |
Why?
|
| DNA | 3 | 2004 | 1358 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 178 | 0.020 |
Why?
|
| Gestational Age | 1 | 1991 | 757 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 1988 | 211 | 0.020 |
Why?
|
| Ischemia | 1 | 2011 | 363 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 616 | 0.020 |
Why?
|
| Electrochemistry | 1 | 1987 | 79 | 0.020 |
Why?
|
| Twins | 1 | 1988 | 241 | 0.020 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 1 | 1986 | 2 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1987 | 161 | 0.020 |
Why?
|
| Common Bile Duct | 2 | 1997 | 14 | 0.020 |
Why?
|
| Organoids | 2 | 1985 | 75 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 616 | 0.020 |
Why?
|
| Portal Vein | 1 | 1987 | 81 | 0.020 |
Why?
|
| Weaning | 1 | 1986 | 48 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 1476 | 0.020 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2005 | 4 | 0.020 |
Why?
|
| Succinate Cytochrome c Oxidoreductase | 1 | 1985 | 2 | 0.020 |
Why?
|
| Cholic Acid | 1 | 1985 | 4 | 0.020 |
Why?
|
| Diet | 1 | 2012 | 1075 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 2 | 1983 | 87 | 0.020 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 1985 | 10 | 0.020 |
Why?
|
| Coenzyme A Ligases | 1 | 1985 | 11 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1985 | 83 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 51 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 2004 | 26 | 0.020 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2004 | 5 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 2004 | 17 | 0.020 |
Why?
|
| Acyltransferases | 1 | 1985 | 46 | 0.020 |
Why?
|
| Ion Channels | 1 | 1985 | 123 | 0.020 |
Why?
|
| Alanine Transaminase | 2 | 1983 | 141 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1984 | 128 | 0.010 |
Why?
|
| Sulfotransferases | 1 | 1984 | 6 | 0.010 |
Why?
|
| Cytosol | 1 | 1985 | 209 | 0.010 |
Why?
|
| Sulfurtransferases | 1 | 1984 | 9 | 0.010 |
Why?
|
| Monoiodotyrosine | 1 | 1983 | 1 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1983 | 39 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 316 | 0.010 |
Why?
|
| Organ Size | 1 | 2004 | 435 | 0.010 |
Why?
|
| Reye Syndrome | 1 | 1983 | 4 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 99 | 0.010 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2003 | 14 | 0.010 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2003 | 17 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 949 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 961 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1983 | 126 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2003 | 52 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1983 | 7 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 406 | 0.010 |
Why?
|
| Caregivers | 1 | 2009 | 714 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1983 | 52 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1984 | 477 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1993 | 1602 | 0.010 |
Why?
|
| Lipase | 1 | 1983 | 65 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1987 | 644 | 0.010 |
Why?
|
| Vomiting | 1 | 1983 | 125 | 0.010 |
Why?
|
| Breath Tests | 1 | 1983 | 85 | 0.010 |
Why?
|
| Liver Circulation | 1 | 1982 | 21 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 1983 | 125 | 0.010 |
Why?
|
| Chickenpox | 1 | 1983 | 94 | 0.010 |
Why?
|
| Sex Factors | 2 | 2004 | 1741 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2209 | 0.010 |
Why?
|
| Duodenum | 1 | 1982 | 63 | 0.010 |
Why?
|
| Middle Aged | 2 | 2010 | 27084 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1984 | 222 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2003 | 308 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1983 | 236 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1983 | 133 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 108 | 0.010 |
Why?
|
| Body Height | 1 | 1982 | 185 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1728 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 262 | 0.010 |
Why?
|
| Imidazoles | 1 | 2002 | 215 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2005 | 616 | 0.010 |
Why?
|
| Colon | 1 | 1983 | 233 | 0.010 |
Why?
|
| Sulfates | 1 | 1981 | 45 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 277 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1868 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2001 | 68 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1983 | 449 | 0.010 |
Why?
|
| Digestive System | 1 | 1980 | 27 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 399 | 0.010 |
Why?
|
| Fasting | 1 | 1981 | 241 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 1983 | 323 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1981 | 268 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2001 | 249 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 1842 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1980 | 115 | 0.010 |
Why?
|
| Pyridines | 1 | 2002 | 425 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1998 | 63 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1998 | 37 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1998 | 56 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1998 | 23 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1998 | 149 | 0.010 |
Why?
|
| Necrosis | 1 | 1998 | 211 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1997 | 56 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1997 | 33 | 0.010 |
Why?
|
| Ethinyl Estradiol | 1 | 1997 | 17 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1997 | 26 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 1997 | 19 | 0.010 |
Why?
|
| Receptors, Prolactin | 1 | 1997 | 8 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 35 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 1997 | 42 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1998 | 97 | 0.010 |
Why?
|
| Canada | 1 | 1998 | 337 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 368 | 0.010 |
Why?
|
| Enterostomy | 1 | 1996 | 8 | 0.010 |
Why?
|
| Endosomes | 1 | 1997 | 125 | 0.010 |
Why?
|
| Acute Disease | 1 | 1979 | 917 | 0.010 |
Why?
|
| 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 1 | 1996 | 1 | 0.010 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 1996 | 9 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1998 | 184 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1998 | 933 | 0.010 |
Why?
|
| Epilepsy | 1 | 1979 | 290 | 0.010 |
Why?
|
| Insulin | 1 | 1984 | 2083 | 0.010 |
Why?
|
| Length of Stay | 1 | 1999 | 963 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 1001 | 0.010 |
Why?
|
| Societies, Medical | 1 | 1998 | 690 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1997 | 832 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1997 | 731 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1993 | 91 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1993 | 25 | 0.010 |
Why?
|
| Copper | 1 | 1993 | 101 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 19299 | 0.010 |
Why?
|
| Organizations | 1 | 1992 | 19 | 0.010 |
Why?
|
| Photochemistry | 1 | 1993 | 125 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1992 | 66 | 0.010 |
Why?
|
| Parents | 1 | 1999 | 1210 | 0.010 |
Why?
|
| Mammals | 1 | 1993 | 251 | 0.010 |
Why?
|
| Proteins | 1 | 1996 | 922 | 0.010 |
Why?
|
| Phylogeny | 1 | 1993 | 802 | 0.010 |
Why?
|
| Chemistry | 1 | 1988 | 39 | 0.010 |
Why?
|
| Brain Death | 1 | 1989 | 32 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1988 | 82 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1992 | 1970 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1998 | 4670 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1993 | 1707 | 0.000 |
Why?
|
| Glycogen Synthase | 1 | 1984 | 7 | 0.000 |
Why?
|
| Liver Glycogen | 1 | 1984 | 19 | 0.000 |
Why?
|
| Receptor, Insulin | 1 | 1984 | 93 | 0.000 |
Why?
|
| Yersinia Infections | 1 | 1984 | 4 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1984 | 85 | 0.000 |
Why?
|
| Campylobacter Infections | 1 | 1984 | 9 | 0.000 |
Why?
|
| Dysentery, Bacillary | 1 | 1984 | 9 | 0.000 |
Why?
|
| Bacteriological Techniques | 1 | 1984 | 64 | 0.000 |
Why?
|
| Clostridium Infections | 1 | 1984 | 56 | 0.000 |
Why?
|
| Escherichia coli Infections | 1 | 1984 | 102 | 0.000 |
Why?
|
| Salmonella Infections | 1 | 1984 | 51 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1992 | 1486 | 0.000 |
Why?
|
| Specimen Handling | 1 | 1984 | 157 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1984 | 321 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 163 | 0.000 |
Why?
|
| Malabsorption Syndromes | 1 | 1980 | 14 | 0.000 |
Why?
|
| Radiography | 1 | 1983 | 826 | 0.000 |
Why?
|
| Glucose | 1 | 1984 | 904 | 0.000 |
Why?
|
| Influenza, Human | 1 | 1983 | 549 | 0.000 |
Why?
|
| Crohn Disease | 1 | 1980 | 197 | 0.000 |
Why?
|